Paeonol suppresses lipopolysaccharide-induced inflammatory cytokines in macrophage cells and protects mice from lethal endotoxin shock

Fundamental and Clinical Pharmacology

Volumn 28, Issue 3, 2014, Pages 268-276

  Chen, Na ^a   Liu, Dianfeng ^a   Soromou, Lanan Wassy ^a   Sun, Jingjing ^a   Zhong, Weiting ^a   Guo, Weixiao ^a   Huo, Meixia ^a   Li, Hongyu ^a   Guan, Shuang ^a   Chen, Zhenwen ^b   Feng, Haihua ^a  

^a JILIN UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Cytokines; Lipopolysaccharide; Paeonol; Pathway; Survival

Indexed keywords

ACETOPHENONE DERIVATIVE; CYTOKINE; LIPOPOLYSACCHARIDE; LIPOPOLYSACCHARIDE, E COLI O55-B5; NONSTEROID ANTIINFLAMMATORY AGENT; PEONOL;

ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; C57BL MOUSE; CELL LINE; CELL SURVIVAL; CHEMISTRY; CULTURE TECHNIQUE; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; FEMALE; IMMUNOLOGY; ISOLATION AND PURIFICATION; MACROPHAGE; PAEONIA; PLANT ROOT; SHOCK, SEPTIC; TOXICITY;

ACETOPHENONES; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL CULTURE TECHNIQUES; CELL LINE; CELL SURVIVAL; CYTOKINES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE, INBRED C57BL; PAEONIA; PLANT ROOTS; SHOCK, SEPTIC;

EID: 84899086164     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/fcp.12019     Document Type: Article

References (41)

1. Feghali C.A., Wright T.M. Cytokines in acute and chronic inflammation. Front. Biosci. (1997) 2 12-26.
2. Morson B.C. Pathology of inflammatory diseases. Proc. R. Soc. Med. (1970) 63 63.
3. Cline M.J. Leukocyte function in inflammation: the ingestion, killing, and digestion of microorganisms. Ser. Haematol. (1970) 3 3-16.
4. Ulevitch R.J., Tobias P.S. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu. Rev. Immunol. (1995) 13 437-457.
5. Angus D.C., Linde-Zwirble W.T., Lidicker J., Clermont G., Carcillo J., Pinsky M.R. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. (2001) 29 1303-1310.
6. Mayeux P.R. Pathobiology of lipopolysaccharide. J. Toxicol. Environ. Health (1997) 51 415-435.
7. Annane D., Aegerter P., Jars-Guincestre M.C., Guidet B. Current epidemiology of septic shock: the CUB-Réa Network. Am. J. Respir. Crit. Care Med. (2003) 168 165-172.
8. Silva E., Pedro Mde A., Sogayar A.C. et al. Brazilian sepsis epidemiological study. Crit. Care (2004) 8 251-260.
9. Hotchkiss R.S., Karl I.E. The pathophysiology and treatment of sepsis. N. Engl. J. Med. (2003) 348 138-150.
10. Monneret G., Venet F., Pachot A., Lepape A. Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony. Mol. Med. (2008) 14 64-78.
11. Hotchkiss R.S., Coopersmith C.M., McDunn J.E., Ferguson T.A. The sepsis seesaw: tilting toward immunosuppression. Nat. Med. (2009) 15 496-497.
12. Parillo J.E. Pathogenetic mechanisms of septic shock. N. Engl. J. Med. (1993) 328 1471-1477.
13. Tang Y., Li B., Wang N. et al. Fluorofenidone protects mice from lethal endotoxemia throughthe inhibition of TNF-alpha and IL-1beta release. Int. Immunopharmacol. (2010) 10 580-583.
14. He D.Y., Dai S.M. Anti-inflammatory and immunomodulatory effects of paeonia lactiflora pall, a traditional chinese herbal medicine. Front. Pharmacol. (2011) 2 10.
15. Zhang L.H., Xiao P.G., Hung Y. Recent progresses in pharmacological and clinical studies of paeonol. Zhongguo Zhong Xi Yi Jie He Za Zhi. (1996) 16 187-190.
16. Li J., Chen C.X., Shen Y.H. Effects of total glucosides from paeony (Paeonialactiflora Pall) roots on experimental atherosclerosis in rats. J. Ethnopharmacol. (2011) 135 469-475.
17. Goto H., Shimada Y., Akechi Y., Kohta K., Hattori M., Terasawa K. Endothelium-dependent vasodilator effect of extract prepared from the roots of Paeonia lactiflora on isolated rat aorta. Planta Med. (1996) 62 436-439.
18. Zhang X.M., Song Y., Ci X.X. et al. Ivermectin inhibits LPS-induced production of inflammatory cytokines and improves LPS-induced survival in mice. Inflamm. Res. (2008) 57 524-529.
19. Jones E., Adcock I.M., Ahmed B.Y. et al. Modulation of LPS stimulated NF-kappaB mediated Nitric Oxide production by PKCepsilon and JAK2 in RAW macrophages. J. Inflamm. (2007) 4 23-31.
20. Ialenti A., Moncada S., Di Rosa M. Modulation of adjuvant arthritis by endogenousnitric oxide. Br. J. Pharmacol. (1993) 110 701-706.
21. Cunha F.Q., Poole S., Lorenzetti B.B., Ferreira S.H. The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Br. J. Pharmacol. (1992) 107 660-664.
22. Abreu M.T., Arditi M. Innate immunity and Toll-like receptors: clinical implications of basic science research. J. Pediatr. (2004) 144 421-429.
23. Aggarwal B.B., Natarajan K. Tumor necrosis factors: developments during the last decade. Eur. Cytokine Netw. (1996) 7 93-124.
24. Fiorentino D.F., Zlotnik A., Mosmann T.R., Howard M., O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. (1991) 146 3444-3451.
25. Berg D.J., Kuhn R., Rajewsky K. et al. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J. Clin. Invest. (1995) 96 2339-2347.
26. Ge'rard C., Bruyns C., Marchant A. et al. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J. Exp. Med. (1993) 177 547-550.
27. Ertel W., Keel M., Steckholzer U., Ungethüm U., Trentz O. Interleukin-10 attenuates the release of proinflammatory cytokines but depresses splenocyte functions in murine endotoxemia. Arch. Surg. (1996) 131 51-56.
28. Grutz G. New insights into the molecular mechanism of interleukin-10-mediated immunosuppression. J. Leukoc. Biol. (2005) 77 3-15.
29. Pan L.L., Dai M. Paeonol from Paeonia suffruticosa prevents TNF-a-induced monocytic cell adhesion to rat aortic endothelial cells by suppression of VCAM-1 expression. Phytomedicine (2009) 16 1027-1032.
30. Romics L., Kodys K., Dolganiuc A. et al. Diverse regulation of NF-kappaB and peroxisome proliferator-activated receptors in murine nonalcoholic fatty liver. Hepatology (2004) 40 376-385.
31. Choi Y.H., Jin G.Y., Li G.A., Yan A.H. Cornuside suppresses lipopolysaccharide-induced inflammatory mediators by inhibiting Nuclear Factor-Kappa B activation in RAW 264.7 Macrophages. Biol. Pharm. Bull. (2011) 34 959-966.
32. Zhang Y.L., Dong C. MAP kinases in immune responses. Cell. Mol. Immunol. (2005) 2 20-27.
33. Chae H.S., Kang O.H., Lee Y.S. et al. Inhibition of LPS-induced iNOS, COX-2 and inflammatory mediator expression by paeonol through the MAPKs inactivation in RAW 264.7 cells. Am. J. Chin. Med. (2009) 37 181-194.
34. Huang H., Chang E.J., Lee Y., Kim J.S., Kang S.S., Kim H.H. A genome-wide microarray analysis reveals anti-inflammatory target genes of paeonol in macrophages. Inflamm. Res. (2008) 57 189-198.
35. Fu P.K., Wu C.L., Tsai T.H., Hsieh C.L. Anti-inflammatory and anticoagulative effects of paeonol on LPS-induced acute lung injury in rats. Evid. Based Complement. Alternat. Med. (2012) 2012 837513.
36. Huh J.E., Yim J.H., Lee H.K., Moon E.Y., Rhee D.K., Pyo S. Prodigiosin isolated from Hahella chejuensis suppresses lipopolysaccharide-induced NO production by inhibiting p38 MAPK, JNK and NF-κBactivation in murine peritoneal macrophages. Int. Immunopharmacol. (2007) 7 1825-1833.
37. Namas R., Zamora R., Namas R. et al. Sepsis: something old, something new, and a systems view. J. Crit. Care (2012) 27 314.e1-11.
38. Fioretto J.R., Martin J.G., Kurokawa C.S. et al. Interleukin-6 and procalcitonin in children with sepsis and septic shock. Cytokine (2008) 43 160-161.
39. Nishida E., Gotoh Y. The MAP kinase cascade is essential for diverse signal transduction pathway. Trends Biochem. Sci. (1993) 18 128-131.
40. Ray L.B., Sturgill T.W. Rapid stimulation by insulin of a serine threonine kinase in 3T3-L1 adipocytes that phosphorylates microtubuleassociated protein 2 in vitro. Proc. Natl Acad. Sci. (1987) 84 1502-1506.
41. Marshall C.J. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell (1995) 80 179-185.